Report projects $69B in instrumentation sales for 2021

By The Science Advisory Board staff writers

March 5, 2021 -- Research firm Strategic Directions International (SDi), a sister company of, projects more than $69 billion in 2021 sales for laboratory analytical and life science instrumentation businesses in a new global report.

SDi's "2021 Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry" covers more than 80 product categories, with in-depth profiles of specific technologies, including innovation, size, and growth potential. Among other themes, SDi analysts noted the regional sources of growth for developing countries in Asia and assessed the potential for various markets to bounce back from the coronavirus pandemic.

Life science instrumentation market adapts to COVID-19
To reflect the new realities of the analytical instrumentation market during the COVID-19 pandemic and in the subsequent pandemic-driven recession, Strategic...
Need for efficiency, COVID-19 vaccine spurs biomanufacturing in 2020
With the urgent need for COVID-19 therapies and vaccines, funding agencies have prioritized biomanufacturing; companies in turn are preparing to ramp...
COVID-19: A double-edged sword for the pharma industry
The COVID-19 pandemic is causing major disruptions to pharmaceutical R&D activities, despite the pressing need for treatments and diagnostics for the...
Shortage of RNA extraction kits threatens coronavirus testing
The weak link in the U.S. response to diagnostic testing for the novel coronavirus SARS-CoV-2 could be a shortage of RNA extraction kits. Fortunately,...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter